市場調查報告書
商品編碼
1617143
Peri -到 2030 年的植體炎治療市場預測:按治療類型、原因類型、植入類型、設備類型、最終用戶和地區進行的全球分析Peri-Implantitis Treatment Market Forecasts to 2030 - Global Analysis By Treatment Type (Non-Surgical Treatments, Surgical Treatments, Combination Treatments and Other Treatment Types), Cause Type, Implant Type, Device Type, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球植體植入炎治療市場規模為 11 億美元,預計預測期內複合年成長率為 10.7%,到 2030 年將達到 21 億美元。
植體周圍植入的治療包括控制植入周圍的發炎和感染。治療選擇取決於症狀的嚴重程度,但通常包括非手術方法,例如機械清洗和消毒清洗以減少細菌負荷。更嚴重的病例需要手術干預,例如皮瓣手術,以進入和清洗更深的區域。抗生素和適當的口腔衛生對於預防復發和長期植入成功至關重要。
根據 NCBI 的數據,在美國平均 2 年追蹤期間,患者層面的植入周圍炎盛行率為 34.0%,植入層面的盛行率為 21%。
增加植入的使用
人工植牙使用的增加極大地推動了市場的發展。隨著越來越多的人選擇人工植牙來替代牙齒,對常見併發症植體周圍植入的有效治療的需求不斷成長。因此,診斷技術和治療方案的進步,包括非手術干預和微創手術,正在推動市場成長。對長期植入成功的關注進一步增加了對專門植體周圍植入治療的需求。
缺乏熟練的專家
市面上缺乏熟練的專家會對患者的治療結果和整體治療效果產生負面影響。由於專業知識有限,植入的診斷和治療可能會延遲或不充分,從而導致更高的植入失敗率和更長的恢復時間。這種短缺也阻礙了技術創新,限制了先進治療的獲得,並增加了現有專家的負擔,導致等待時間更長和治療可用性降低。
民眾口腔衛生意識
民眾對口腔衛生意識的提高正在對市場產生正面影響。隨著越來越多的人意識到口腔衛生的重要性,尤其是植入周圍的口腔衛生,預防植體周圍植入已成為人們關注的焦點。關於適當護理、衛生習慣和早期發現的教育宣傳活動有助於改善植體周圍植入的預防和管理。這種意識的提高推動了對有效治療方案的需求,並促進了長期植入的成功。
治療費用高
市面上高昂的治療費用是許多患者治療的主要障礙。先進的手術,包括外科手術和專門治療,通常需要昂貴的設備和專業知識,這增加了成本。這種經濟負擔限制了患者獲得所需治療的機會,並可能導致他們的醫療狀況惡化和植入失敗。結果,治療被推遲或放棄,導致長期健康併發症惡化並增加整體醫療費用。
COVID-19 大流行導致選擇性牙科手術(包括植入相關治療)的延誤,並嚴重擾亂了植體周圍植入的治療市場。鎖門和保持社交距離的措施導致就診人數減少、人員短缺以及對緊急護理的關注,從而延遲了植體周圍植入的診斷和治療。此外,財務不安全和對非必要服務的限制導致成本增加和獲得專門護理的機會有限,影響整體治療結果。
預計鈦植入市場在預測期內將成為最大的市場
由於人工植牙的普及,鈦植入預計將在預測期內佔據最大的市場佔有率。鈦的生物相容性和耐腐蝕性使其成為植入的首選材料。植入設計、表面改性和治療方法的進步正在推動市場擴張,重點是提高長期植入成功率並減少感染和骨質流失等併發症。
牙科診所預計在預測期內複合年成長率最高
預計牙科診所產業在預測期內將呈現最高的複合年成長率。牙科診所擴大採用先進的診斷工具和治療技術,例如雷射療法、抗菌藥物和再生手術,來控制植體周圍植入。人們對植入失敗風險的認知不斷提高,以及對有效干預措施的需求不斷增加,這推動了對這些環境下專門治療的需求,從而推動了市場的成長。
由於人工植牙數量的增加,預計北美地區在預測期內將佔據最大的市場佔有率。雷射療法和再生技術等診斷和治療技術的進步正在推動市場發展。該地區完善的醫療保健基礎設施可支援市場擴張以及對牙科治療服務的高需求,使該地區成為植體周圍植入治療創新的關鍵中心。
由於口腔健康問題日益嚴重、意識不斷提高以及支持性醫療保健政策,亞太地區預計將在預測期內實現最高成長率。該地區的齲齒和牙周病患病率高得驚人,尤其是老年人。提高口腔衛生意識對於推動植體周圍植入治療的需求至關重要。此外,有利的政府政策和醫療基礎設施的進步也有助於市場擴張。
According to Stratistics MRC, the Global Peri-Implantitis Treatment Market is accounted for $1.1 billion in 2024 and is expected to reach $2.1 billion by 2030 growing at a CAGR of 10.7% during the forecast period. Peri-implantitis treatment involves managing inflammation and infection around a dental implant, typically affecting the tissues surrounding the implant. Treatment options vary depending on the severity of the condition but often include non-surgical methods like mechanical debridement (cleaning) and antiseptic rinses to reduce bacterial load. In more severe cases, surgical interventions such as flap surgery may be necessary to access and clean deeper areas. Antibiotics and proper oral hygiene are essential for preventing recurrence and ensuring long-term implant success.
According to NCBI, the prevalence of peri-implantitis was 34.0% on the patient level and 21% on the implant level over an average follow-up of 2 years in the U.S.
Increasing usage of dental implants
The increasing use of dental implants has significantly boosted the market. As more people opt for dental implants for tooth replacement, the demand for effective treatments for peri-implantitis, a common complication, rises. This has led to advancements in diagnostic techniques and therapeutic options, including non-surgical interventions and minimally invasive procedures, driving growth in the market. The focus on long-term implant success further enhances the demand for specialized peri-implantitis treatments.
Shortage of skilled specialists
The shortage of skilled specialists in the market negatively impacts patient outcomes and the overall effectiveness of treatments. With limited expertise, the diagnosis and management of peri-implantitis may be delayed or inadequate, leading to higher failure rates of implants and prolonged recovery times. This shortage also hampers innovation, restricts access to advanced care, and increases the burden on existing specialists, resulting in longer waiting times and reduced treatment availability.
Public awareness of oral hygiene
Rising public awareness of oral hygiene has positively impacted the market. As more individuals recognize the importance of maintaining oral health, especially around dental implants, there is an increased focus on preventing peri-implantitis. Educational campaigns on proper care, hygiene practices, and early detection contribute to better prevention and management of the condition. This growing awareness drives demand for effective treatment options and promotes long-term implant success.
High treatment costs
High treatment costs in the market pose a significant barrier to access for many patients. The advanced procedures, including surgical interventions and specialized care, often require expensive equipment and expertise, driving up costs. This financial burden can limit patient access to necessary treatments, potentially leading to worsened conditions or implant failure. As a result, individuals may delay or forgo treatment, exacerbating long-term health complications and increasing overall healthcare costs.
The COVID-19 pandemic significantly disrupted the peri-implantitis treatment market by causing delays in elective dental procedures, including implant-related treatments. Lockdowns and social distancing measures led to reduced patient visits, staff shortages, and a focus on urgent care, slowing down the diagnosis and management of peri-implantitis. Additionally, financial uncertainties and restrictions on non-essential services led to increased costs and limited access to specialized care, affecting overall treatment outcomes.
The titanium implants segment is expected to be the largest during the forecast period
The titanium implants segment is expected to account for the largest market share during the projection period due to the increasing prevalence of dental implant procedures. Titanium's biocompatibility and resistance to corrosion make it a preferred material for implants. Advancements in implant design, surface modifications, and therapeutic approaches are driving market expansion, with a focus on improving long-term implant success rates and reducing complications such as infection and bone loss.
The dental clinics segment is expected to have the highest CAGR during the forecast period
The dental clinics segment is expected to have the highest CAGR during the extrapolated period. Dental clinics are increasingly adopting advanced diagnostic tools and treatment techniques, including laser therapy, antimicrobial agents, and regenerative procedures, to manage peri-implantitis. The growing awareness of implant failure risks and the need for effective interventions are driving demand for specialized treatments in these settings, fostering market growth.
North America region is estimated to account for the largest market share during the forecast period due to the rising number of dental implants. Advances in diagnostic and therapeutic technologies, including laser treatments and regenerative techniques, are driving the market. The region's well-established healthcare infrastructure, along with a high demand for dental care services, supports the market's expansion, positioning the region as a key hub for peri-implantitis treatment innovations.
Asia Pacific is expected to register the highest growth rate over the forecast period driven by increasing oral health issues, rising awareness, and supportive healthcare policies. The prevalence of dental caries and periodontal disease is alarmingly high in the region, particularly among older adults. There is a growing awareness regarding oral health, which is crucial for driving demand for peri-implantitis treatments. Moreover, Favorable government policies and advancements in healthcare infrastructure are also contributing to market expansion.
Key players in the market
Some of the key players in Peri-Implantitis Treatment market include Pfizer Inc., Cadila Pharmaceuticals, R N. Laboratories, Triveni Chemicals, Arthrex, Zimmer Biomet Dental, Stryker, Smith & Nephew, Danaher, 3M, Meyer Dental Laboratory, Cochlear Limited, Medtronic, Bicon Dental Implants, Cendres+Metaux, Straumann AG and Fotona.
In July 2024, Fotona announced the opening of the Laser & Health (LA&HA) Academy Training Center in Malaysia. Designed to support all Fotona users and practitioners, the new center aims to enhance knowledge, foster collaboration, and achieve clinical excellence.
In February 2024, Straumann has announced the complete acquisition of GalvoSurge, a Swiss medical device company specializing in dental implant care and maintenance solutions. GalvoSurge has developed an innovative approach to support peri-implantitis treatment, with its CE-marked device launched in 2020.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.